Waldencast PLC (NASDAQ:WALD) Receives Consensus Rating of “Moderate Buy” from Brokerages

Waldencast PLC (NASDAQ:WALDGet Free Report) has been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $4.9667.

WALD has been the topic of a number of analyst reports. Telsey Advisory Group decreased their price target on Waldencast from $4.00 to $3.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 20th. Weiss Ratings restated a “sell (e+)” rating on shares of Waldencast in a report on Wednesday, October 8th.

View Our Latest Research Report on Waldencast

Hedge Funds Weigh In On Waldencast

A number of hedge funds have recently modified their holdings of WALD. Milestones Administradora de Recursos Ltda. raised its stake in shares of Waldencast by 10.3% during the third quarter. Milestones Administradora de Recursos Ltda. now owns 2,425,677 shares of the company’s stock valued at $4,803,000 after acquiring an additional 225,677 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Waldencast by 62.2% in the second quarter. Geode Capital Management LLC now owns 586,566 shares of the company’s stock worth $1,437,000 after purchasing an additional 224,905 shares during the last quarter. McAdam LLC increased its holdings in Waldencast by 174.6% during the 3rd quarter. McAdam LLC now owns 63,014 shares of the company’s stock valued at $125,000 after purchasing an additional 40,063 shares during the period. Rhumbline Advisers raised its position in Waldencast by 15.2% during the 1st quarter. Rhumbline Advisers now owns 61,630 shares of the company’s stock valued at $185,000 after purchasing an additional 8,151 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its position in Waldencast by 12.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 57,702 shares of the company’s stock valued at $114,000 after purchasing an additional 6,516 shares during the last quarter. Hedge funds and other institutional investors own 41.97% of the company’s stock.

Waldencast Trading Up 1.1%

WALD opened at $1.82 on Friday. Waldencast has a 12 month low of $1.48 and a 12 month high of $4.18. The business’s 50-day moving average price is $1.87 and its 200-day moving average price is $2.16.

Waldencast Company Profile

(Get Free Report)

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.

Recommended Stories

Analyst Recommendations for Waldencast (NASDAQ:WALD)

Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.